The EMA has approved Cullinan Therapeutics’ clinical trial application for CLN-978, a drug intended to treat rheumatoid ...

The interplay between sex and serious bacterial infections, including bacteremia and sepsis, is complex and more research is ...

The Sabin Vaccine Institute has begun a trial to evaluate its Marburg vaccine, with the first doses being given to subjects ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

Hoth Therapeutics has reported interim data from a trial of HT-001, a drug designed for treating pruritus associated with ...

The World Health Organization (WHO) has released an update on polio following the March 2025 meeting of the International ...

With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

More than just a tool for advancing pipelines, trial efficiency is the name of the game when it comes to synthetic control ...

Corxel Pharmaceuticals has received investigational new drug (IND) application clearance from the US FDA for the trial of ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

Pfizer still has another obesity pill in development, PF-07976016, which is currently in a Phase IIa trial. The gold standard ...

Pheast Therapeutics has treated the first subject in a multi-centre Phase I trial for PHST001, aimed at treating advanced ...